|
Title
|
|
|
|
Genotype-phenotype links in frontotemporal lobar degeneration
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Frontotemporal lobar degeneration (FTLD) represents a group of neurodegenerative brain diseases with highly heterogeneous clinical, neuropathological and genetic characteristics. This high degree of heterogeneity results from the presence of several different underlying molecular disease processes; consequently, it is unlikely that all patients with FTLD will benefit from a single therapy. Therapeutic strategies for FTLD are currently being explored, and tools are urgently needed that enable the selection of patients who are the most likely to benefit from a particular therapy. Definition of the phenotypic characteristics in patients with different FTLD subtypes that share the same underlying disease processes would assist in the stratification of patients into homogeneous groups. The most common subtype of FTLD is characterized by TAR DNA-binding protein 43 (TDP43) pathology (FTLD-TDP). In this group, pathogenic mutations have been identified in four genes: C9orf72, GRN, TBK1 and VCP. Here, we provide a comprehensive overview of the phenotypic characteristics of patients with FTLD-TDP, highlighting shared features and differences among groups of patients who have a pathogenic mutation in one of these four genes. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Nature reviews : neurology
|
|
|
Publication
|
|
|
|
New York
:
Nature publishing group
,
2018
|
|
|
ISSN
|
|
|
|
1759-4758
1759-4766
|
|
|
DOI
|
|
|
|
10.1038/S41582-018-0009-8
|
|
|
Volume/pages
|
|
|
|
14
:6
(2018)
, p. 363-378
|
|
|
ISI
|
|
|
|
000433426600012
|
|
|
Pubmed ID
|
|
|
|
29777184
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|